Poly (amidoamine) dendrimer-mediated hybrid formulation for combination therapy of ramipril and hydrochlorothiazide
详细信息 查看全文
- 作者：Mayank Kumar Singh
- 关键词：Ramipril (PubChem CID ; 5362129) ; Hydrochlorothiazide (PubChem CID ; 3639) ; Acetonitrile (PubChem CID ; 6342) ; Sodium Perchlorate (PubChem CID ; 522606) ; Orthophosphoric Acid (PubChem CID ; 1004) ; Hydrochloric Acid (PubChem CID ; 313) ; Sodium Hydroxide (PubChem CID ; 14798) ; HPLC Water (PubChem CID ; 962) ; Dendrimers ; Diaminobutane (DAB) G4.0 PAMAM-NH2 (NS-D204) ; DAB G4.0 PAMAM-OH (NS-D274) and DAB G3.5 PAMAM-COONa (NS-D233)
- 刊名：European Journal of Pharmaceutical Sciences
- 出版年：2017
- 出版时间：1 January 2017
- 年：2017
- 卷：96
- 期：Complete
- 页码：84-92
- 全文大小：1824 K
- 卷排序：96
文摘
We present a dendrimer-based hybrid formulation strategy to explore the potential of poly (amidoamine) PAMAM dendrimers to be used as drug carriers for combination therapy of an anti-hypertensive drug ramipril (RAPL) and a diuretic hydrochlorothiazide (HCTZ). The drug-dendrimer complexes were prepared by phase-equilibration method. The results showed that the solubility of RAPL and HCTZ was dependent on dendrimer concentration and pH of dendrimer solution. The solubility profile of both RAPL and HCTZ dendrimer complexes illustrated a non-linear relationship with dendrimer concentration. At 0.8% (w/v) dendrimer concentration, solubility of RAPL was increased 4.91 folds with amine-terminated while for HCTZ, solubility enhancement was highest (3.72 folds) with carboxy-terminated. The complexes were characterized by Fourier transform infrared spectroscopy, nuclear magnetic resonance analysis and high performance liquid chromatography. In-vitro drug dissolution performance of pure drugs, individual drug loaded dendrimer formulations and hybrid formulations was studied in USP dissolution medium (pH 7.0) and in simulated gastric fluid (pH 1.2). Dendrimer mediated formulations showed faster and complete dissolution compared to pure RAPL or HCTZ. Surprisingly, similar pattern of dissolution profile was established with hybrid formulations as compared to individual drug loaded dendrimers. The dendrimer-based hybrid formulations were found to be stable at dark and refrigerated conditions up to 5 weeks. Conclusively, the proposed formulation strategy establishes a novel multitasking platform using dendrimer for simultaneous loading and delivery of multiple drugs for pharmaceutical applications.